Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-24T03:28:36.325Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of anti-N-methyl-d-aspartate (NMDA) antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis – CORRIGENDUM

Published online by Cambridge University Press:  28 January 2014

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Corrigendum
Information
Psychological Medicine , Volume 44 , Issue 12 , September 2014 , pp. 2488
Copyright
Copyright © Cambridge University Press 2014 

In the recently published article by Pollak et al. (2013), a crucial word is missing from the title and should be corrected.

The additional word is receptor and the correct title should read:

Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis.

The error has now been rectified in the original online and print PDF and HTML copies of this article.

References

Pollak, TA, McCormack, R, Peakman, M, Nicholson, TR, David, AS. Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychological Medicine. Published online 13 December 2013 , doi:10.1017/S003329171300295X.Google Scholar